Stay updated on Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial page.

Latest updates to the Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and the prior v3.4.1 notice about government funding and operating status was removed, with no changes to the study details or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding status notice at the top of the page. Updated the page revision from v3.4.0 to v3.4.1 and removed the previous revision note.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a 'Show glossary' option to provide term definitions. Updated QC-related labels and revision notes (including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0') and removed older variants ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4').'SummaryDifference0.2%

- Check42 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedThe locations section was consolidated into a single 'Locations' section, adding California, Colorado, Florida, Michigan, Oregon, and New South Wales. Old state-specific location blocks (e.g., California Locations, Colorado Locations, Florida Locations, Michigan Locations, Oregon Locations, New South Wales Locations) were removed.SummaryDifference0.6%

- Check85 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1 as a minor page update; there are no changes to study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial page.